These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Feb 8, 2017
Sierra Oncology, Inc. (NASDAQ: SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response therapeutics for the treatment of patients with cancer,...
Jan 9, 2017
- Company plans to study synthetic lethality in genetically-defined patient cohorts - - Preclinical research underway studying DDR and immuno-oncology combinations - VANCOUVER, Jan. 9, 2017 /CNW/...
Jan 9, 2017
- Sierra Oncology to trade on NASDAQ under the symbol 'SRRA' - - Company to present at the BIOTECH Showcase in San Francisco on January 11th - VANCOUVER, Jan. 9, 2017 /CNW/ - ProNAi Therapeutics,...
Nov 14, 2016
- "Beyond PARP - Next Generation DDR Therapeutics" scheduled for 8:00 am on November 17th, 2016 - VANCOUVER, Nov 14, 2016 /CNW/ - ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage drug...
Nov 10, 2016
ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients with cancer, today reported its...